Clinical, functional, and radiological profile of fibrotic interstitial lung disease at high altitude: a registry-based cohort from two referral centres in Bogotá, Colombia (2,600 metres above sea level)

The Air Up High: A Story of Lungs and Mountains

Imagine your lungs are like a pair of delicate, stretchy balloons inside your chest. Usually, these balloons are filled with air that has just the right amount of oxygen to keep your body running smoothly. But sometimes, those balloons get stiff and scarred, like an old rubber band that's been stretched too many times. This condition is called Interstitial Lung Disease (ILD). It's a group of diseases where the tissue between the tiny air sacs in your lungs gets inflamed and turns into fibrous scar tissue, making it hard to breathe.

Now, imagine taking those same lungs and moving them up a mountain. As you climb higher, the air gets thinner. It's not that there is less oxygen in the atmosphere, but the air pressure drops, making it harder to grab onto that oxygen. This is called hypobaric hypoxia. For most people, the body adapts to this by breathing faster or making more red blood cells. But for someone with scarred, stiff lungs, this "thin air" environment is like trying to run a marathon while wearing a heavy backpack. The question scientists have been asking is: How does living high up in the mountains change the story of lung disease? Does the thin air make the scars worse? Does it change which diseases are most common? This paper dives into that exact mystery, looking at patients living in a city perched high in the Andes mountains.

---

The High-Altitude Lung Detective Story

In this study, researchers acted like detectives, gathering clues from 148 patients with fibrotic lung disease (the kind with permanent scarring) who were treated at two major hospitals in Bogotá, Colombia. Bogotá is a fascinating place for this experiment because it sits 2,600 meters (about 8,500 feet) above sea level. That's high enough that the air is significantly thinner than at the beach, creating a unique "pressure cooker" for the lungs.

The team wanted to see what these patients looked like: how old they were, what caused their lung trouble, how bad their breathing was, and what the pictures of their lungs (CT scans) showed. They found a group of patients who were, on average, 70 years old, with more women than men. Interestingly, nearly half of them had never smoked a cigarette in their lives, which is a big clue that something other than smoking was causing the damage.

Who had the trouble?
The most common culprit turned out to be Connective Tissue Disease (CTD-ILD), found in 36% of the patients. Think of connective tissue as the "glue" that holds your body's joints and organs together. In these patients, their immune system got confused and attacked that glue, which accidentally scarred the lungs too. The second most common cause was Hypersensitivity Pneumonitis (HP) at 26%. You can imagine HP as an allergic reaction to something in the air—like mold, bird feathers, or dust—that the lungs get tired of fighting, eventually turning into scar tissue.

Surprisingly, the classic "smoker's lung disease" known as Idiopathic Pulmonary Fibrosis (IPF) was actually the least common of the big three, making up only 15% of the cases. This is different from what scientists often see in low-altitude cities, suggesting that living high up might shift the balance of which diseases are most likely to strike.

How bad was it?
The patients were struggling. Even though it took a median of 6 months from the first symptom to get a diagnosis, the toll was heavy. More than half of the patients (56%) had severe shortness of breath, described as feeling like they were running up a steep hill just to walk across a room. Because the air was so thin, 45% of the patients needed oxygen tanks at home just to keep their blood oxygen levels up.

When the researchers looked at the lung function tests, they saw a "mild restrictive pattern." Imagine trying to blow up a balloon that has been stiffened by glue; it doesn't expand as much as it should. However, the researchers noted something tricky: because these people live at high altitude, their lungs might naturally be bigger and stronger than people at sea level. So, even though the tests showed "mild" restriction, the patients might actually be feeling much worse than the numbers suggest. It's like a fish that is used to deep water trying to swim in a shallow pond; the pond looks deep to a human, but to the fish, it's a struggle.

The "HP" Group Had the Hardest Time
When they broke the patients down by disease type, the group with Hypersensitivity Pneumonitis (HP) was hit the hardest. They had the lowest lung capacity and the worst drop in oxygen levels when they walked. It's as if their lungs were the most sensitive to the thin mountain air, losing their ability to grab oxygen faster than the other groups.

The X-Ray Puzzle
The doctors also checked if the diagnosis matched the X-ray pictures. They found a very strong link (a statistical "yes" with a p-value of less than 0.001). If a patient had CTD, the X-ray looked one way; if they had HP, it looked another. This is good news because it means doctors can often guess the disease just by looking at the scan. However, the paper warns that the X-ray isn't a magic wand. About 19% of the patients were labeled "unclassifiable," meaning the doctors couldn't figure out exactly what was wrong, even with the scans. This suggests that in Bogotá, as in many places, doctors need to sit in a big room together (a multidisciplinary team) to solve the puzzle, rather than relying on just one test.

The Treatment Gap
Finally, the study looked at what medicines the patients were taking. While some were on steroids to calm the inflammation, very few were getting the newer, stronger drugs designed to stop scarring (called antifibrotics). Only 12% of the patients were on nintedanib and 3.5% on pirfenidone. Even among the patients who definitely had the scarring disease (IPF), only 36% were getting these specific drugs. The authors suggest this isn't because the drugs don't work, but likely because of hurdles in getting them or the high cost in the local healthcare system.

The Bottom Line
This paper paints a picture of lung disease in the high Andes. It tells us that in Bogotá, the most common lung scarring comes from autoimmune issues and allergies, not smoking. It shows that living at 2,600 meters makes breathing much harder for these patients, forcing many to rely on oxygen. While the doctors can often match the disease to the X-ray, there is still a gap in getting the right, modern treatments to the people who need them most. The study suggests that the thin air of the mountains adds a special, difficult layer to the story of lung disease, one that doctors everywhere need to understand better.